Рет қаралды 9,728
Almost 100 years ago, the first clinical use of insulin took place at Toronto General Hospital. Today, scientists at University Health Network are building on this legacy, revolutionizing the way we treat diabetes, which affects 1 in 3 Canadians.
Join us to discover how world-class researchers, Drs. Cristina Nostro and Trevor Reichman at UHN’s McEwen Stem Cell Institute and Ajmera Transplant Centre are taking the next quantum leap in diabetes therapy, focused on the ultimate goal of eliminating the need for daily insulin injections in people living with Type 1 diabetes by generating insulin-producing cells for transplantation.
During this exclusive virtual experience, you will have the opportunity to see first hand, through the eyes of our scientists, the incredible innovation that happens every single day at the McEwen Stem Cell Institute and the Ajmera Transplant Centre.
Wednesday, March 17, 2021 | 5 - 6 p.m.
Dr. Cristina Nostro
Principal Investigator, McEwen Stem Cell Institute;
Harry Rosen Chair in Diabetes and Regenerative Medicine Research, UHN
Dr. Trevor Reichman
Director, Pancreas Transplant Program,
Ajmera Transplant Centre, UHN
Moderated by Christian Cote
Host of UHN's Behind the Breakthrough Podcast